Afatinib
Cat.No:IA1670 Solarbio
CAS:439081-18-2
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:Off-white to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Angiogenesis >
AfatinibCAS:439081-18-2
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:Off-white to yellow Solid
Qty:
Size:
CAS | 439081-18-2 |
Name | Afatinib |
Molecular Formula | C24H25ClFN5O3 |
Molecular Weight | 485.94 |
Solubility | Soluble in DMSO |
Purity | HPLC≥98% |
Appearance | Off-white to yellow Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 1308068-626-2 |
MDL | MFCD12407405 |
SMILES | CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4 |
Target Point | EGFR |
Passage | Angiogenesis;Protein Tyrosine Kinase/RTK; JAK/STAT Signaling |
Background | Afatinib irreversibly inhibits EGFR/ErbB. |
Biological Activity | Afatinib (BIBW2992),是酪氨酸激酶ErbB家族的不可逆抑制剂,通过结合表皮生长因子受体(EGFR)/表皮生长因子受体2(HER2)的激酶结构域,从而下调ErbB信号,其IC50值分别为0.5 nM和14 nM。[1] |
In Vitro | Afatinib在许多过表达EGFR和表达HER2的细胞系中抑制EGF诱导的EGFR磷酸化和细胞增殖,如A431、NIH-3T3-HER2、NCI-N87和BT-474[1]。 |
In Vivo | Afatinib也被广泛应用于各种动物模型来研究EGFR/HER2的作用。在异种移植和转基因肺癌模型中,口服Afatinib后可抑制癌细胞的生长和存活,诱导肿瘤衰退[2]。此外,Afatinib是已知的EGFR阻断剂,已获批用于EGFR突变非小细胞肺癌患者的治疗[3]。 |
Data Literature Source | [1]. Eskens FA,Mom CH,Planting AS,Gietema JA,Amelsberg A,Huisman H,et al. A phase I dose escalation study of BIBW 2992,an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on,2-week off schedule in patients with advanced solid tumours. Br J Cancer 2008,98:80-85. [2]. Li D,Ambrogio L,Shimamura T,Kubo S,Takahashi M,Chirieac LR,et al. BIBW2992,an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models. Oncogene 2008,27:4702-4711. [3]. Engle JA,Kolesar JM. Afatinib: A first-line treatment for selected patients with metastatic non-small-cell lung cancer. Am J Health Syst Pharm 2014,71:1933-1938. |
Unit | Bottle |
Specification | 5mg 10mM*1mL in DMSO 10mg 20mg |
Afatinib不可逆地抑制EGFR/ErbB。
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
A prognostic biomarker NRG1 promotes U?87 MG glioblastoma cell malignancy by inhibiting autophagy via ERBB2/AKT/mTOR pathway
Click to check >>Author:Jia-zhe Lin, Nuan Lin, Wei-Jiang Zhao
IF:4.0000
Publish_to:JOURNAL OF CELLULAR BIOCHEMISTRY
PMID:37450666